In-situ fenestrated versus physician-modified endografts in the endovascular treatment of thoracic and complex abdominal aortic pathologies in modern vascular surgery

Key Points

• The research examines the effectiveness and safety of in-situ fenestrated versus physician-modified endografts in treating complex aortic pathologies.
• Compared systemic complication rates between in-situ fenestrated and physician-modified endografts.
• Evaluated outcomes post-procedure, focusing on thoracic and abdominal aortic pathologies.
• In-situ fenestrated endografts exhibited lower rates of systemic complications.
• Early outcomes related to thoracic and abdominal aortic issues were similar despite risk of ischemia.